arrow
H

Hans-Peter Sinn

Institute of Pathology
H指数:68
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The contribution of rare germline variants to the immune landscape of breast cancer

稀有胚系变异对乳腺癌免疫景观的贡献

2026-05-090
OA
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma

BRCA缺陷性输卵管卵巢高级别浆液性癌的生存临床病理及分子预测因子

2026-04-010
OAAI
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

在转移性乳腺癌中实施精准肿瘤学:全面基因组分析的临床影响——CATCH研究经验

2025-10-310
OAAI
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025

AGO乳腺癌委员会关于乳腺癌手术治疗的建议:妇科肿瘤工作组(AGO)2025年更新

2025-09-170
PREAI
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
2024-11-010
OAAI
Exploring Circulating Leukocyte RNA Expression: Implications for Treatment Outcomes and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo Trial
2024-05-020
PRE
Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy?

保乳治疗中的常规标本x线摄影: 新辅助治疗后术中切缘评估的有用工具?

2023-06-111
OAAI
Spatial and temporal heterogeneity of predictive and prognostic signatures in triple-negative breast cancer treated with neoadjuvant combination immune-chemotherapy
2023-03-010
PRE
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker

高级别子宫内膜间质肉瘤伴YWHAE::NUTM2基因融合表现出复发性CDKN2A改变,p16染色缺失是预后不良的标志物

2023-03-0115
PRE
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

CCNE1与输卵管卵巢高级别浆液性癌患者的生存: 卵巢肿瘤组织分析联盟研究

CANCER
IF5.1
2022-12-2614
OAAI
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

认知: 新辅助化疗后高危早期乳腺癌患者的前瞻性精确肿瘤学试验

2022-12-016
OAAI
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
2022-11-1911
OAAI
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

高级别浆液性卵巢癌中FOXJ1蛋白表达增加与总生存期改善相关: 卵巢肿瘤组织分析联盟研究

2022-11-023
OA